Novel paradigm for immunotherapy of ovarian cancer by engaging prophylactic immunity against hepatitis B virus-Reference-Cited by-同舟云学术

Novel paradigm for immunotherapy of ovarian cancer by engaging prophylactic immunity against hepatitis B virus

Published:2016-11-30 Issue:1 Volume:5 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Malecki Marek¹²³,Putzer Emily⁴,Quach Caroline⁵,Dodivenaka Chaitanya⁶,Tombokan Xenia⁷

Affiliation:

1. National Magnetic Resonance FacilityNational Institutes of HealthMadisonWIUSA

2. Phoenix Biomolecular Engineering FoundationSan FranciscoCAUSA

3. University of WisconsinMadisonWIUSA

4. District of ColumbiaDepartment of HealthWashingtonDCUSA

5. Long Island UniversityBrookvilleNYUSA

6. South Dakota State UniversityBrookingsSDUSA

7. Bruker Bio‐Spin CorporationThe WoodlandsTXUSA

Funder

National Science Foundation

National Institutes of Health

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1186/s40169-016-0125-2

Reference29 articles.

1. Ten-Year Relative Survival for Epithelial Ovarian Cancer

2. Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification

3. Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

4. Overexpression of HER‐2/neu is associated with poor survival in advanced epithelial ovarian cancer;Berchuck A;Cancer Res,1990

5. Overexpression of c‐erbB‐2 oncogene in primary ovarian cancers: incidence and prognostic significance in 243 patients;Meden H;Geburtshilfe Frauenheilkd,1992

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Could hepatitis B vaccine act as an adjuvant to lower risk and relapses of cancer?;Clinical and Experimental Pharmacology and Physiology;2019-05-07

2. Natural killer cells inhibit metastasis of ovarian carcinoma cells and show therapeutic effects in a murine model of ovarian cancer;Experimental and Therapeutic Medicine;2018-06-22

3. Immunotherapy as an Option for Cancer Treatment;Archivum Immunologiae et Therapiae Experimentalis;2017-10-12